CureAge Therapeutics Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$665K
- Investors
-
5
CureAge Therapeutics General Information
Description
Developer of genetic therapies designed to treat peripheral nerve disorders. The company specializes in ribonucleic acid systems with a focus on neurofibromatosis and gene therapy platforms tailored for rare neurological conditions, enabling patients with inherited nerve disorders to access targeted and potentially transformative treatments.
Contact Information
Website
www.cureagetx.comCorporate Office
- 16 Stapleton Court, Packington Road
- London W3 8FB
- England, United Kingdom
Corporate Office
- 16 Stapleton Court, Packington Road
- London W3 8FB
- England, United Kingdom
CureAge Therapeutics Timeline
CureAge Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Grant | 16-Jul-2026 | $665K | Completed | Generating Revenue | ||
| 2. Accelerator/Incubator | 11-Dec-2025 | Completed | Generating Revenue | |||
| 1. Seed Round | 08-Oct-2025 | Completed | Startup |
CureAge Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordianry |
CureAge Therapeutics Signals
CureAge Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innovate UK | Government | |||
| Charles River Incubator Program | Accelerator/Incubator | |||
| Children's Tumor Foundation | Corporation | Minority | ||
| Deep Science Ventures | Venture Capital | Minority | ||
| Nothing is Forever | Other | Minority |
CureAge Therapeutics FAQs
-
When was CureAge Therapeutics founded?
CureAge Therapeutics was founded in 2024.
-
Where is CureAge Therapeutics headquartered?
CureAge Therapeutics is headquartered in London, United Kingdom.
-
What is the size of CureAge Therapeutics?
CureAge Therapeutics has 5 total employees.
-
What industry is CureAge Therapeutics in?
CureAge Therapeutics’s primary industry is Biotechnology.
-
Is CureAge Therapeutics a private or public company?
CureAge Therapeutics is a Private company.
-
What is CureAge Therapeutics’s current revenue?
The current revenue for CureAge Therapeutics is .
-
Who are CureAge Therapeutics’s investors?
Innovate UK, Charles River Incubator Program, Children's Tumor Foundation, Deep Science Ventures, and Nothing is Forever have invested in CureAge Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process